Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.

Autor: Fitzpatrick T; Canadian Center for Vaccinology, IWK Health and Dalhousie University, Halifax, Nova Scotia, Canada; Public Health Ontario, Toronto, Ontario, Canada., Yamoah P; Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Lacuesta G; Halifax Allergy and Asthma Associates, Dalhousie University, Halifax, Nova Scotia, Canada., Sadarangani M; Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Vaccine Evaluation Center, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Cook V; Division of Immunology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Pourshahnazari P; Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Kalicinsky C; Section of Allergy and Clinical Immunology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Upton JEM; Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Cameron SB; Division of Immunology, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Zaborniak K; Section of Allergy and Clinical Immunology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Kanani A; Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lam G; Vancouver Costal Health and Providence Health, Vancouver, British Columbia, Canada., Burton C; Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Constantinescu C; Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Pernica JM; Department of Pediatrics, McMaster University and McMaster Children's Hospital, Hamilton, Ontario, Canada., Abdurrahman Z; Department of Pediatrics, McMaster University and McMaster Children's Hospital, Hamilton, Ontario, Canada., Betschel S; Division of Allergy and Clinical Immunology, St. Michael's Hospital, Toronto, Ontario, Canada., Drolet JP; Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Quebec, Canada., De Serres G; Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Quebec, Canada., Quach C; Division of Infectious Diseases, CHU Sainte Justine, Universite de Montreal, Montreal, Quebec, Canada., Des Roches A; Primary Immunodeficiency Clinic, Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada., Chapdelaine H; Primary Immunodeficiency Clinic, Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada., Salvadori MI; Department of Pediatrics, McGill University, Montreal, Quebec, Canada; Public Health Agency of Canada, Ottawa, Ontario, Canada., Carignan A; Department of Microbiology and Infectious Diseases, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada., McConnell A; Pediatric Infectious Diseases, Jim Pattison Children's Hospital, Saskatoon, Saskatchewan, Canada., Pham-Huy A; Division of Infectious Diseases, Immunology and Allergy, CHEO, University of Ottawa, Ottawa, Ontario, Canada., Buchan CA; Division of Infectious Diseases, Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Cowan J; Division of Infectious Diseases, Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Hildebrand K; Vaccine Evaluation Center, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada., Top KA; Canadian Center for Vaccinology, IWK Health and Dalhousie University, Halifax, Nova Scotia, Canada; Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Electronic address: ktop@ualberta.ca.

Publikováno v: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126078. Date of Electronic Publication: 2024 Jun 22.

Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.

Autor: Keeshan A; Dept of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Galipeau Y; Department of Biochemistry, University of Ottawa, Ottawa, Ontario, Canada., Heiskanen A; Dept of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Collins E; School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., McCluskie PS; Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Arnold C; Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Saginur R; Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada., Booth R; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada., Little J; School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., McGuinty M; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada., Buchan CA; Dept of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Crawley A; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network, Ottawa, Ontario, Canada., Langlois MA; Coronavirus Variants Rapid Response Network, Ottawa, Ontario, Canada.; Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Cooper C; Dept of Medicine, University of Ottawa, Ottawa, Ontario, Canada ccooper@toh.ca.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network, Ottawa, Ontario, Canada.; Division of Infectious Diseases, Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa,Canada, Ontario, Canada.

Publikováno v: BMJ open [BMJ Open] 2023 Oct 31; Vol. 13 (10), pp. e077714. Date of Electronic Publication: 2023 Oct 31.

Cohort profile: S top the Spread Ottawa (SSO) - a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.

Autor: Collins E; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada ecoll098@uottawa.ca.; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Galipeau Y; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada., Arnold C; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada., Bosveld C; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Heiskanen A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Keeshan A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Nakka K; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.; Sprott Center for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Shir-Mohammadi K; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada., St-Denis-Bissonnette F; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Tamblyn L; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Vranjkovic A; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Wood LC; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Booth R; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Immunology Section, Eastern Ontario Regional Laboratory Association (EORLA), Ottawa, Ontario, Canada., Buchan CA; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Crawley AM; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada., Little J; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; The Knowledge Synthesis and Application Unit (KSAU), University of Ottawa, Ottawa, Ontario, Canada., McGuinty M; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Saginur R; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Ottawa Health Science Network Research Ethics Board (OHSN-REB), Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Langlois MA; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada., Cooper CL; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: BMJ open [BMJ Open] 2022 Sep 08; Vol. 12 (9), pp. e062187. Date of Electronic Publication: 2022 Sep 08.

Early Warning of Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation Using Heart Rate Variability and Serum Biomarkers.

Autor: Buchan CA; Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: abuchan@toh.ca., Li HO; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Herry CL; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Scales N; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., MacPherson P; Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Faller E; Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Bredeson C; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Huebsch L; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Hodgins M; Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Seely AJE; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Departments of Critical Care Medicine and Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Mar; Vol. 28 (3), pp. 166.e1-166.e8. Date of Electronic Publication: 2021 May 05.

Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic.

Autor: Weiss MJ; Transplant Québec, Montréal, QC, Canada.; CHU de Québec - Université Laval Research Center, Population Health and Optimal Health Practices Research Unit, Trauma-Emergency-Critical Care Medicine, Université Laval, QC, Canada.; Canadian Donation and Transplantation Research Program (CDTRP), Ottawa, ON, Canada., Hornby L; Canadian Donation and Transplantation Research Program (CDTRP), Ottawa, ON, Canada.; System Development - Organ and Tissue Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada., Foroutan F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, ON, Canada., Belga S; Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Bernier S; Faculty of Medicine, Université Laval, QC, Canada., Bhat M; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Multiorgan Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada., Buchan CA; Division of Infectious Diseases, Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Gagnon M; Division of Nephrology and Multi-Organ Transplant Program, Department of Medicine, McGill University, Montreal, QC, Canada., Hardman G; National Health Service Blood and Transplant, Bristol, United Kingdom., Ibrahim M; National Health Service Blood and Transplant, Bristol, United Kingdom.; Kings College, London, United Kingdom., Luo C; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Luong ML; Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montréal, QC, Canada., Mainra R; Division of Nephrology, University of Saskatchewan, Saskatoon, SK, Canada.; St. Paul's Hospital, Saskatchewan Transplant Program, Saskatoon, SK, Canada., Manara AR; National Health Service Blood and Transplant, Bristol, United Kingdom.; Department of Intensive Care Medicine, Southmead Hospital, Bristol, United Kingdom., Sapir-Pichhadze R; Division of Nephrology and Multi-Organ Transplant Program, Department of Medicine, McGill University, Montreal, QC, Canada.; Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, QC, Canada., Shalhoub S; Division of Infectious Diseases, Department of Medicine, Western University, London, ON, Canada., Shaver T; Southern Alberta Organ and Tissue Donation Program, Calgary, AB, Canada., Singh JM; Department of Medicine, University of Toronto, Toronto, Ontario, ON, Canada.; Trillium Gift of Life Network, Toronto, ON, Canada., Srinathan S; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Thomas I; National Health Service Blood and Transplant, Bristol, United Kingdom.; Department of Intensive Care Medicine, Southmead Hospital, Bristol, United Kingdom., Wilson LC; System Development - Organ and Tissue Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada., Wilson TM; Transplant Research Foundation of British Columbia, Vancouver, BC, Canada.; Patient Partner, Canadian Donation and Transplantation Research Program.; The Alberta ORGANization Group, Edmonton, AB, Canada., Wright A; Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Mah A; Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Publikováno v: Transplantation direct [Transplant Direct] 2021 Sep 07; Vol. 7 (10), pp. e755. Date of Electronic Publication: 2021 Sep 07 (Print Publication: 2021).